YDES is YD Bio Ltd (Healthcare) — a non-dividend-paying stock. Trading at $4.80. Market cap: $340M.
Stock snapshot
| Price | $4.80 |
| Market cap | $340M |
| Sector | Healthcare |
| Exchange | NGM |
| Pays dividend | No |
About YDES
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
Related non-dividend companies
Other non-dividend stocks investors research alongside YDES. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is YDES's current stock price?
YDES (YD Bio Ltd) is currently trading at $4.80.
Does YDES pay a dividend?
YDES (YD Bio Ltd) does not currently pay a regular dividend.
Track YDES in DiviDrip
Add YDES to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search YDES and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.